Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma

Overview

Journal Anal Cell Pathol (Amst)

Specialties Cell Biology
Oncology
Pathology

Date 2020 Feb 25

PMID 32089989

Citations 21

Authors

Zhigang Ren

Xiaochao Ma

Zhenfeng Duan

Xinhua Chen

Affiliations

Soon will be listed here.

Citing Articles

miR‑100: A key tumor suppressor regulatory factor in human malignant tumors (Review).

Zhang L, Zhang J, Zhang X, Liu S, Qi C, Gao S Int J Mol Med. 2025; 55(4).

PMID: 40017111 PMC: 11875724. DOI: 10.3892/ijmm.2025.5508.

Efficacy of sorafenib combined with transarterial chemoembolization in the treatment of advanced hepatocellular carcinoma: A meta-analysis.

Xu M, Zhou S, Li Y, Zhang C, Liao D, Wang X World J Gastrointest Oncol. 2025; 17(2):98927.

PMID: 39958535 PMC: 11756001. DOI: 10.4251/wjgo.v17.i2.98927.

GGCT participates in the malignant process of hepatocellular cancer cells by regulating the PTEN/PI3K/AKT pathway through binding to EZH2.

He J, Wang L, Lv M, Yuan Y Discov Oncol. 2025; 16(1):129.

PMID: 39918720 PMC: 11806167. DOI: 10.1007/s12672-025-01882-z.

The therapeutic role of naringenin nanoparticles on hepatocellular carcinoma.

Elwan A, Mohamed T, Beltagy D, El Gamal D BMC Pharmacol Toxicol. 2025; 26(1):3.

PMID: 39754228 PMC: 11697747. DOI: 10.1186/s40360-024-00823-w.

M2-polarized tumor-associated macrophage-secreted exosomal lncRNA NEAT1 upregulates galectin-3 by recruiting KLF5 and promotes HCC immune escape.

Yuan W, Sun Q, Zhu X, Li B, Zou Y, Liu Z J Cell Commun Signal. 2024; 19(1):e12060.

PMID: 39720765 PMC: 11666343. DOI: 10.1002/ccs3.12060.

References

Yu L, Schwabe R . The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol. 2017; 14(9):527-539. PMC: 6467288. DOI: 10.1038/nrgastro.2017.72. View

Kobayashi T, Aikata H, Kobayashi T, Ohdan H, Arihiro K, Chayama K . Patients with early recurrence of hepatocellular carcinoma have poor prognosis. Hepatobiliary Pancreat Dis Int. 2017; 16(3):279-288. DOI: 10.1016/s1499-3872(16)60181-9. View

Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F . Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66(2):115-32. DOI: 10.3322/caac.21338. View

Siegel R, Miller K, Jemal A . Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1):7-30. DOI: 10.3322/caac.21387. View

Hubscher S . What is the long-term outcome of the liver allograft?. J Hepatol. 2011; 55(3):702-717. DOI: 10.1016/j.jhep.2011.03.005. View